病毒再激活-话题@MedSci

#病毒再激活#

5篇内容 | 265人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1799597, encodeId=88141e9959754, content=<a href='/topic/show?id=c08ae090298' target=_blank style='color:#2F92EE;'>#病毒再激活#</a>, objectTitle=Clinical Gastro H：长期接受肿瘤坏死因子拮抗剂治疗的患者乙型肝炎病毒再激活和肝毒性的发生率, objectType=article, longId=155520, objectId=b82d1555203b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b82d1555203b, replyNumber=0, likeNumber=26, createdTime=2019-02-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b82d1555203b, moduleTitle=Clinical Gastro H：长期接受肿瘤坏死因子拮抗剂治疗的患者乙型肝炎病毒再激活和肝毒性的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b82d1555203b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1799596, encodeId=becd1e99596d5, content=<a href='/topic/show?id=c08ae090298' target=_blank style='color:#2F92EE;'>#病毒再激活#</a>, objectTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, objectType=article, longId=145196, objectId=e18514519623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e18514519623, replyNumber=0, likeNumber=43, createdTime=2019-01-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e18514519623, moduleTitle=J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e18514519623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1799595, encodeId=53b71e99595c6, content=<a href='/topic/show?id=c08ae090298' target=_blank style='color:#2F92EE;'>#病毒再激活#</a>, objectTitle=Transpl Int：肝移植受者的巨细胞病毒再激活与较高的心血管风险有关, objectType=article, longId=132040, objectId=9903132040e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9903132040e4, replyNumber=0, likeNumber=39, createdTime=2018-10-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9903132040e4, moduleTitle=Transpl Int：肝移植受者的巨细胞病毒再激活与较高的心血管风险有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9903132040e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1799594, encodeId=9c5c1e9959402, content=<a href='/topic/show?id=c08ae090298' target=_blank style='color:#2F92EE;'>#病毒再激活#</a>, objectTitle=JAMA Inter Med：免疫功能危重症患者巨细胞病毒再激活的抗病毒治疗, objectType=article, longId=97684, objectId=7bb89e684e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bb89e684e6, replyNumber=0, likeNumber=31, createdTime=2018-01-30, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bb89e684e6, moduleTitle=JAMA Inter Med：免疫功能危重症患者巨细胞病毒再激活的抗病毒治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bb89e684e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1799593, encodeId=24951e9959319, content=<a href='/topic/show?id=c08ae090298' target=_blank style='color:#2F92EE;'>#病毒再激活#</a>, objectTitle=乙肝病毒再激活的发病率、致病机制和预防, objectType=article, longId=30706, objectId=e55030e063d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e55030e063d, replyNumber=0, likeNumber=34, createdTime=2014-11-25, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e55030e063d, moduleTitle=乙肝病毒再激活的发病率、致病机制和预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e55030e063d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

病毒再激活

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#病毒再激活#

Clinical Gastro H：长期接受肿瘤坏死因子拮抗剂治疗的患者乙型肝炎病毒再激活和肝毒性的发生率

2019-02-09

fengyi812 (审核中...)

前往app查看评论内容

#病毒再激活#

J Viral Hepat：DAA治疗HBV和HCV共感染代偿期肝硬化患者时，HBV病毒再激活的风险

2019-01-19

fengyi812 (审核中...)

前往app查看评论内容

#病毒再激活#

Transpl Int：肝移植受者的巨细胞病毒再激活与较高的心血管风险有关

2018-10-09

智智灵药 (审核中...)

前往app查看评论内容

#病毒再激活#

JAMA Inter Med：免疫功能危重症患者巨细胞病毒再激活的抗病毒治疗

2018-01-30

fengyi812 (审核中...)

前往app查看评论内容

#病毒再激活#

乙肝病毒再激活的发病率、致病机制和预防

2014-11-25

科室
- - 订阅+
  - 更多科室
工具
服务